VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
XLV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
XLVHealth Care Select Sector SPDR Fund
$166.18
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksXLVP/E History

XLV logoHealth Care Select Sector SPDR Fund (XLV) P/E Ratio History

Insufficient Data

Valuation data unavailable. · Data 2026–2026

Current P/E (TTM)
N/A
5Y Avg P/E
N/A
Median N/A
5Y Percentile
N/A
PEG Ratio
N/A
TTM EPSN/A
PriceN/A
Earnings YieldN/A
EPS Growth (1Y)N/A
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our XLV DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

XLV Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Sector
N/AvsN/A
N/A
vs. S&P 500
N/Avs24.5
N/A
PEG Analysis
N/A
P/E ÷ EPS Growth
Consensus & Technical Research Suite
Open XLV Terminal

XLV Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

XLV — Frequently Asked Questions

Quick answers to the most common questions about buying XLV stock.

What is XLV's P/E ratio?

Health Care Select Sector SPDR Fund (XLV) trailing twelve-month P/E ratio is N/A, based on TTM diluted EPS of N/A. The 5-year average P/E is N/A and the historical range spans N/A to N/A.

Is XLV stock overvalued or undervalued?

XLV current P/E: N/A. 5-year average P/E: N/A. Percentile: N/A.

Is XLV stock expensive?

XLV is fairly valued relative to its own history. The current P/E of N/A is near the 5-year average of N/A (N/A percentile of historical range).

What is XLV's historical P/E range?

Over the past 5 years, XLV's P/E ratio has ranged from N/A to N/A, with a median of N/A and an average of N/A. The current P/E of N/A places the stock at the N/A percentile of this range. Full historical data spans 2026–2026.

How does XLV's P/E compare to the S&P 500?

XLV current P/E: N/A. S&P 500 median P/E: 24.5x.

How does XLV's valuation compare to sector peers?

Health Care Select Sector SPDR Fund P/E of N/A can be benchmarked against sector peers in the comparison table on this page.

What is XLV's PEG ratio?

XLV PEG ratio is N/A. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is XLV's earnings yield?

XLV earnings yield is N/A, the inverse of its N/A P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

XLV P/E Ratio History

Quarterly valuation multiple from closing price and trailing EPS

Current-
Period Avg-
Range- - -
Change-
0 quarters- - -